President Donald Trump will direct his top health officials to conduct a systematic review of the childhood vaccinations ...

Previously, Galmed announced the grant of new use patent for a combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH. The new patent extends Aramchol's patent ...

Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing and ...

This peer-reviewed publication marks an important milestone following initial release of study information in August 2024 (see "Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT"). The ...

Advisors to the Centers for Disease Control and Prevention (CDC) voted 8-3 Friday to recommend that a mother without ...

Q3 2026 Earnings Call Transcript December 2, 2025 Asana, Inc. misses on earnings expectations. Reported EPS is $-0.28779 EPS, ...

Generative Artificial Intelligence or GenAI has been a useful tool for people to create new content, such as text, images, ...

Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced the appointment of Luke Gill, ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

CNW/ -- (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced ...

Hundreds of studies, including gold-standard clinical trials, challenge Health Secretary Robert F. Kennedy Jr.’s claim that ...